Guest guest Posted November 17, 2007 Report Share Posted November 17, 2007 doi:10.1016/j.cgh.2007.07.008 Original article—liver, pancreas, and biliary tract Prophylaxis of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis by an Endoscopic Pancreatic Spontaneous Dislodgement Stent Atsushi Sofuni, Hiroyuki Maguchi‡, Takao Itoi, Akio Katanuma‡, Hiroyuki Hisai§, Teitetsu Niido¶, Masayuki Toyota, Tsuneshi Fujii#, Youji Harada¶ and Tadanori Takada Background & Aims: Pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) is the most common and potentially serious complication of ERCP. The frequency of post-ERCP pancreatitis generally is reported to be between 1% and 9%. One cause of pancreatitis is retention of pancreatic juice resulting from papilledema after the procedure. We conducted a randomized controlled multicenter study to evaluate whether placement of a temporary pancreatic stent designed for spontaneous dislodgement prevents post-ERCP pancreatitis. Methods: The subjects were 201 consecutive patients who underwent ERCP. The patients were randomized into the stent placement group (S group = 98) or the nonstent placement group (nS group = 103). The stent used was 5F in diameter, 3 cm in length, straight, and unflanged inside. Results: Stents were placed successfully in 96% of the S group, and spontaneous stent dislodgment was recognized in 95.7% of those. The mean duration to dislodgment was 2 days, and there were no severe complications. The overall frequency of post-ERCP pancreatitis was 8.5%. The frequency of post-ERCP pancreatitis in the S and nS groups was 3.2% and 13.6%, respectively, showing a significantly lower frequency in the S group (P = .019). The mean increase in amylase level in the pancreatitis patients was significantly higher in the nS group (P = .014). Conclusions: The randomized controlled multicenter trial showed that placement of a pancreatic spontaneous dislodgment stent significantly reduces post-ERCP pancreatitis. Abbreviations: ERCP, endoscopic retrograde cholangiopancreatography; nS group, nonstent placement group; PS, pancreatic duct stent; PSDS, pancreatic spontaneous dislodgement stent; S group, stent placement group Address requests for reprints to: Atsushi Sofuni, MD, PhD, Department of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjyuku-ku, Tokyo, 160-0023 Japan. fax: (81) 3-5381-6654. Clinical Gastroenterology and Hepatology Volume 5, Issue 11, November 2007, Pages 1339-1346 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.